Updating RU 486 development.
Baulieu
E E
EE
D000021:Abortifacient Agents, Steroidal; D018864:Cultural Diversity; D017277:Drug Approval; D004357:Drug Synergism; D005260:Female; D005602:France; D033161:Government Regulation; D006801:Humans; D038622:Internationality; D015735:Mifepristone / Q000008:administration & dosage* / Q000600:supply & distribution; D016595:Misoprostol / Q000008:administration & dosage; D037841:Pregnant People; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation
D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone